ClinicalTrials.gg
RecruitingNCT05321550NFR-CSUpdated Jan 5, 2024

The Nociceptive Flexion Reflex as a Diagnostic Tool of Central Sensitization

An observational study in Central Sensitisation, Fibromyalgia and Neck Pain, sponsored by University Ghent. Recruiting at 1 site in Belgium. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-05.

Sponsored by University Ghent · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Apr 2022; still recruiting 4 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
240
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Fibromyalgia with a site in Belgium — 7 open to participants now, 7 under way, none of them phase 3. Fibromyalgia · Belgium.

Started
2022
with 2 others
Observational
9 of 23
5 open now
Registered
15th of 23
by date
Lead sponsor
3 of 23
University Ghent

Among the 23 studies in Fibromyalgia with a site in Belgium, this one is one of 3 that started in 2022, is one of 9 observational ones, and was the 15th registered.

Fibromyalgia

1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.

Browse Fibromyalgia studies →

Open to participants now

7 of the 23 studies in Fibromyalgia with a site in Belgium are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Fibromyalgia with a site in Belgium, or all of them as a file.
02

Study summary

This experimental study will investigate whether the decreased NFR threshold and increased NFR temporal summation, which are frequently observed in chronic pain patients, are only symptomatic manifestations that occur in the involved limb and indicate peripheral sensitization or generalized manifestations that are also present in the non-involved limbs and thus indicate central sensitization. To gain an idea of the presence of central sensitization, this study will also investigate whether there are increased perception and decreased pain thresholds in response to electrical, thermal, and mechanical stimulation, as well as whether there is a decreased conditioned pain modulation. To investigate this, it is essential to examine different pain populations and locations, in particular, acute pain versus chronic pain populations to compare peripheral versus central sensitization, respectively. Recently, our research group has shown that patients with a traumatic origin of chronic neck pain (chronic whiplash-associated disorders) show central sensitization in contrast to patients with a non-traumatic origin (chronic idiopathic neck pain) who demonstrate only indications for peripheral sensitization. Therefore, this study will also distinguish between complaints of traumatic and non-traumatic origin.

The measurements will be performed at different locations, namely the lower and upper limbs. To determine whether the differences depend on the measurement location (= location where experimental nociceptive stimulation is administered) and symptom location (= location of clinical nociceptive stimulation), different patient populations will be compared with each other, as well as with a healthy control population. In acute and chronic whiplash patients and patients with acute and chronic idiopathic neck pain complaints, the complaints are primarily localized in the upper limb. It is hypothesized that in chronic neck pain patients (both whiplash and idiopathic neck pain patients) abnormal values are found in both the upper and lower limbs compared to the healthy controls due to central sensitization. In acute neck pain patients (both whiplash and idiopathic neck pain) only abnormal values in the arm are expected and not in the leg as a result of peripheral sensitization. It is hypothesized that patients with neck pain of traumatic origin will show a stronger sensitization than those with neck pain of non-traumatic origin. In acute and chronic low back pain patients, the complaints are primarily localized in the lower body quadrant. As a result of central sensitization in the chronic low back pain patients, abnormal values are expected in both the upper and lower limbs, while only abnormal values in the leg are expected as a result of peripheral sensitization in the acute low back pain patients. Finally, this study will investigate whether chronic low back and neck pain patients show a similar pattern of central sensitization as fibromyalgia patients, a population with generalized complaints that are primarily attributed to central sensitization.

03

Conditions studied

  • Central Sensitisation
  • Fibromyalgia
  • Neck Pain
  • Low Back Pain
  • Whiplash
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

  • Fibromyalgia patients (n=30) diagnosed according to the 2010 ACR-criteria
  • Patients with non-specific, idiopathic neck pain complaints which are acute (n=30) or chronic (n=30)
  • Patients with neck pain complaints of traumatic origin type whiplash grade 1 (pain, stiffness or tenderness of the neck and no objective physical abnormalities) and grade 2 (neck complaints and musculoskeletal disorders such as reduced range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders which is acute (n=30) or chronic (n=30)
  • Patients with non-specific, idiopathic back pain complaints which are acute (n=30) or chronic (n=30)
  • Healthy controls (n=30) matched based on age, sex and BMI

Eligibility criteria

Inclusion Criteria Fibromyalgia patients:

  • diagnosed according to 2010 ACR-criteria

Inclusion Criteria neck pain patients:

  • having idiopathic neck pain complaints or having grade 1 (pain, stiffness or tenderness of the neck and without objective physical abnormalities) or grade 2 (neck complaints and musculoskeletal disorders such as decreased range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders

Inclusion Criteria low back pain patients:

  • having idiopathic low back pain complaints

Inclusion Criteria healthy controls:

  • no history of serious pain complaints (e.g. severe migraine, fibromyalgia, etc.)
  • no low back or neck pain complaints with an intensity of ≥2/10 on a visual analogue scale in the past year and of such severity that the daily activities were disrupted and a (para)medic was consulted

Exclusion Criteria:

  • history of severe respiratory (e.g. cystic fibrosis), orthopedic (e.g. whiplash trauma), neurological (e.g. cerebrovascular incident), cardiovascular (e.g. severe hypertension), or endocrinological (e.g. diabetes) disorders
  • recent psychological trauma (e.g. post-traumatic stress disorder)
  • history of spinal surgery (e.g. lumbar discectomy), spinal trauma (e.g. vertebral fracture), or severe spinal deformities (e.g. spondylolisthesis)
  • ≥35 (due to potential difficulties in obtaining an NFR in severely overweight individuals)
  • having pacemakers and defibrillators (absolute exclusion criteria for electrical stimulus stimulation, i.e. TENS)
  • pregnancy, lactation, or within 1 year postpartum
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
240 participants (estimated)
Patient registry
No

Groups and cohorts

  • Fibromyalgia patients

    Fibromyalgia patients diagnosed according to the 2010 ACR-criteria

  • Neck pain patients

    * Patients with non-specific, idiopathic neck pain complaints * Patients with neck pain complaints of traumatic origin type whiplash grade 1 (pain, stiffness or tenderness of the neck and no objective physical abnormalities) and grade 2 (neck complaints and musculoskeletal disorders such as reduced range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders

  • Low back pain patients

    Patients with non-specific, idiopathic back pain complaints

  • Healthy controls

    Age, sex and BMI-matched healthy controls

06

What researchers measure

Primary outcomes

  1. Quantitative sensory testing (QST) - electrical detection threshold

    Determination of sensory detection thresholds in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.

    Time frame: Baseline

  2. Quantitative sensory testing (QST) - electrical pain threshold

    Determination of sensory pain threshold in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.

    Time frame: Baseline

  3. Quantitative sensory testing (QST) - thermal detection threshold

    Determination of sensory detection thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: * cold detection threshold * warmth detection threshold

    Time frame: Baseline

  4. Quantitative sensory testing (QST) - thermal pain threshold

    Determination of sensory pain thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: * cold pain threshold * heat pain threshold

    Time frame: Baseline

  5. Quantitative sensory testing (QST) - discrimination between thermal stimuli

    Determination of the number of paradoxical heat sensations in response to alternating cold and warm stimuli delivered to the skin using a thermode.

    Time frame: Baseline

  6. Quantitative sensory testing (QST) - tactile detection threshold

    Determination of tactile detection threshold, assessed using Von Frey monofilaments, recorded in mN

    Time frame: Baseline

  7. Quantitative sensory testing (QST) - mechanical pain threshold

    Determination of mechanical pain threshold, assessed using pinprick stimulators, recorded in mN

    Time frame: Baseline

  8. Quantitative sensory testing (QST) - sensitivity to pressure stimuli

    Determination of pressure pain threshold, assessed using pressure algometry, recorded in kg

    Time frame: Baseline

  9. Quantitative sensory testing (QST) - temporal summation of electrical stimuli

    Determination of temporal summation in response to electrical stimuli delivered transcutaneously over the skin of the n. suralis and n. medianus. The numerical pain rating in response to these stimuli (range 0 - 100) will be recorded.

    Time frame: Baseline

  10. Quantitative sensory testing (QST) - spinal hyperexcitability

    Determination of spinal hyperexcitability using the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded in mA

    Time frame: Baseline

  11. Quantitative sensory testing (QST) - temporal summation of spinal hyperexcitability

    Determination of temporal summation of the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded using a numeric pain rating scale (range 0 - 100)

    Time frame: Baseline

  12. Quantitative sensory testing - conditioned pain modulation

    Determination of condition pain modulation (aka. pain inhibits pain) by means of a heterotopic noxious counterstimulation paradigm. Test stimuli comprise of pressure pain threshold assessments and application of a heat stimulus (using a thermode) corresponding to a temperature eliciting a visual analog scale rating of 5/10. Test stimuli will be applied before, during and after the conditioning stimulus which is the immersion of the hand in a hot circulating water bath of 45.5°C.

    Time frame: Baseline

Secondary outcomes

  1. Central sensitization inventory

    Self-report measure of signs and symptoms associated with central sensitization

    Time frame: Baseline

  2. Douleur Neuropathique 4 Questionnaire

    Clinician administered questionnaire for evaluation of signs and symptoms associated with neuropathic pain

    Time frame: Baseline

  3. Pain catastrophizing scale

    Self-report measure of pain perceptions and cognitions

    Time frame: Baseline

  4. Pain vigilance and awareness questionnaire

    Self-report measure assessing preoccupation with and attention to pain

    Time frame: Baseline

  5. Tampa scale for kinesiophobia

    Self-report measure assessing fear of movement

    Time frame: Baseline

  6. International physical activity questionnaire

    Self-report measure of physical activity in preceeding 7 days

    Time frame: Baseline

  7. Patient-reported outcomes measurement information system - physical functioning

    Self-report measure of health-related domains relating to physical functioning

    Time frame: Baseline

  8. Patient-reported outcomes measurement information system - anxiety

    Self-report measure of health-related domains relating to anxiety

    Time frame: Baseline

  9. Patient-reported outcomes measurement information system - depression

    Self-report measure of health-related domains relating to depression

    Time frame: Baseline

  10. Patient-reported outcomes measurement information system - fatigue

    Self-report measure of health-related domains relating to fatigue and sleep disruption

    Time frame: Baseline

  11. Patient-reported outcomes measurement information system - participation

    Self-report measure of health-related domains relating to participation in social activities

    Time frame: Baseline

  12. Patient-reported outcomes measurement information system - pain interference

    Self-report measure of health-related domains relating to pain interference

    Time frame: Baseline

  13. Injustice Experience Questionnaire

    Self-report measure of perceived injustice

    Time frame: Baseline

  14. Pain Disability Index

    Self-report measure of pain-related disability

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2022 (actual). Primary completion is estimated for Oct 2024, 30 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 22, 2022
First posted
Apr 11, 2022
StartActual
Apr 21, 2022
Primary completionEst.
Oct 2024
CompletionEst.
Oct 2024
Last update
Jan 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05321550
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
Apr 11, 2022
Start date
Apr 21, 2022
Primary completion
Oct 2024 (estimated)
Completion
Oct 2024 (estimated)
Last update
Jan 5, 2024

Study contacts

Sophie Van Oosterwijck
Contact
sophie.vanoosterwijck@ugent.be
+329 332 69 22
Jessica Van Oosterwijck
Contact
jessica.vanoosterwijck@ugent.be
Jessica Van Oosterwijck
principal investigator · University Ghent

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion